2019 Annual Meeting | C88 - Mild Cognitive Impairment: Implications for Clinicians
Program Materials Program Evaluations
| 01:00 PM - 01:05 PM EDT | Introduction |
Introduction
Ronald C. Petersen, MD, PhD, FAAN |
| 01:05 PM - 01:50 PM EDT | Speaker |
Overview of MCI
Ronald C. Petersen, MD, PhD, FAAN |
| 01:50 PM - 02:30 PM EDT | Speaker |
Treatment and Management of MCI
David J. Gill, MD, FAAN |
| 02:30 PM - 03:00 PM EDT | Q&A |
Cases, Questions, and Answers
|
| Ronald C. Petersen, MD, PhD, FAAN | Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
| David J. Gill, MD, FAAN | Dr. Gill has nothing to disclose. |